African Coral Snake 🆕 High-Quality

There is no specific antivenom for the Cape Coral Snake. Hospital treatment focuses on managing symptoms.

Endemic to Southern Africa, they are found in the Western and Northern Cape of South Africa, Namibia, and the Karoo region.

While their bites are considered dangerous, they are generally not considered life-threatening to humans, though they can cause serious sickness. african coral snake

As active hunters, they feed on small lizards, geckos, and rodents. Venom and Medical Significance

The Cape Coral Snake is often confused with the harmless ( Telescopus semiannulatus ). However, the Coral Snake’s black head and distinct, bright, and clean banding help differentiate it from its mimics, say the Orianne Society . There is no specific antivenom for the Cape Coral Snake

Here is a detailed look at this elusive, high-contrast reptile. Appearance and Identification

They are small snakes, generally ranging from 30 to 40 cm, though some can reach up to 60–75 cm in length. While their bites are considered dangerous, they are

When threatened, they behave differently than true cobras—they rear up, flatten their necks slightly to form a narrow hood, and hiss loudly. They are notoriously feisty and will strike repeatedly, say the African Snakebite Institute .

X
Stay ahead with
Tip Sheet!
Free newsletter: the hottest new books, features and more
african coral snake
X
X
Email Address

Password

Log In Forgot Password

Premium online access is only available to PW subscribers. If you have an active subscription and need to set up or change your password, please click here.

New to PW? To set up immediate access, click here.

NOTE: If you had a previous PW subscription, click here to reactivate your immediate access. PW site license members have access to PW’s subscriber-only website content. If working at an office location and you are not "logged in", simply close and relaunch your preferred browser. For off-site access, click here. To find out more about PW’s site license subscription options, please email Mike Popalardo at: .

To subscribe: click here.